With commercial insurance: Monoferric Patient Solutions Copay Assistance Program — as little as $0, up to $4,000 per calendar year. With Medicare: the Monoferric card can’t be used. The Assistance Fund (TAF) – Iron Deficiency Anemia Copay Assistance Program is on a waitlist as of October 12, 2026.
See what this patient owes after assistance →
4 assistance programs for Monoferric patients · 2 open today
Two Pharmacosmos programs: the Monoferric Patient Solutions Copay Assistance Program Program, a $0-per-dose commercial card capped at $2,000 per treatment and $4,000 a year, and Patient Assistance, free drug for uninsured patients or those with a coverage gap. Neither reaches a Medicare patient's coinsurance.
Choose the patient's insurance below to see which programs apply.
Current status · Award amounts · Eligibility · Direct application links July 30, 2026
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Monoferric’s card can’t be used with Medicare. These funds may help. They open and close with donations, so call before telling a Monoferric patient no.
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Monoferric · IDA, oral iron failed or not tolerated · Commercial insurance
Eligible patients may pay $0
Example · Monoferric · 1000 mg · 100 units · commercial plan · deductible met · 20% coinsurance · allowed amounts at the Medicare reference rate
| Without assistance | With Monoferric Patient Solutions Copay Assistance Program | |
|---|---|---|
| Drug responsibility | $437.54 | $0.00 |
| Administration (96365) | $13.43 | $13.43 |
| Patient owes | $450.97 | $13.43 |
Estimated patient savings: $437.54
CareCost calculates the drug and administration lines using the patient’s payer rate and benefits; this example uses the Medicare rate as a reference.
Maximum award $5,000
PAN Foundation fund for government-insured patients with Iron Deficiency Anemia (confirmed diagnosis).
Also available if this patient’s coverage falls short
Free Monoferric Patient Solutions Patient Assistance (Free Drug) for eligible patients
Change the diagnosis to see only the programs that apply to your patient.
| Task | ✓ |
|---|---|
| Find programs for the patient's insurance | ✓ |
| See whether the program is open | ✓ |
| See maximum award | ✓ |
| Review key eligibility requirements | ✓ |
| Open the official application | ✓ |
| Calculate cost before assistance | ✓ |
| Apply the program benefit | ✓ |
| Calculate what the patient still owes | ✓ |
Commercial insurance — The Monoferric Patient Solutions Copay Assistance Program Program is Pharmacosmos's copay program: patients pay $0 per dose, and the program pays up to $2,000 per treatment, up to $4,000 per calendar year. It excludes Medicare, Medicaid and government insurance. It covers the drug only — the 96365 infusion fee and the office visit are billed separately. View current program ↑
Uninsured or a coverage gap — Monoferric Patient Solutions Patient Assistance ships Monoferric free directly to the provider for patients who are uninsured or have a coverage gap, at or below 300% of the federal poverty level, with no cap on the number of doses. The shipment is the drug alone — the office visit and the 96365 infusion fee still go on the patient's bill.
Medicare — Manufacturer copay savings cannot be used when government insurance is paying for Monoferric; the federal Anti-Kickback Statute is why, per HHS OIG guidance on copayment coupons, and it is also why the Monoferric Patient Solutions Copay Assistance Program Program excludes Medicare, Medicaid and government insurance outright. The Patient Assistance program is not a fallback either: its eligibility is limited to patients who are uninsured or have a coverage gap, at or below 300% of the federal poverty level. On a 1,000 mg visit, a Medicare patient's 20% coinsurance is $450.97 on $2,254.84 allowed against $13.43 with the card ($0 for the drug plus the $13.43 share of the infusion) — 32 times as much.
Why the diagnosis selector doesn't change the result — Neither Monoferric program is gated by diagnosis. Eligibility runs on the patient's insurance status, and on household income for the Patient Assistance program. IDA with oral iron failure (D50.9) and non-dialysis CKD (D63.1) both qualify the same way for whichever program matches the patient's insurance.
Yes. The Monoferric Patient Solutions Copay Assistance Program Program is Pharmacosmos's commercial-only copay program: patients pay $0 per dose, and the program pays up to $2,000 per treatment, up to $4,000 per calendar year. It excludes Medicare, Medicaid and government insurance. It covers the drug only, not the $67.14 96365 infusion fee or the office visit. Apply on monoferric.com ↗ Calculate cost with the program →
No. The Monoferric Patient Solutions Copay Assistance Program Program excludes Medicare, Medicaid and government insurance. On a 1,000 mg visit, a Medicare patient's 20% coinsurance is $450.97 on $2,254.84 allowed against $13.43 with the card ($0 for the drug plus the $13.43 share of the infusion) — 32 times as much. The Patient Assistance free-drug program is not a Medicare fallback either: its eligibility needs the patient to be uninsured or have a coverage gap, at or below 300% of the federal poverty level.
Patients who are uninsured or have a coverage gap, with household income at or below 300% of the federal poverty level. The program ships Monoferric free directly to the provider, with no cap on the number of doses — no insurance billing involved. It covers the drug only; the office visit and the 96365 infusion fee are billed separately. Apply on monoferric-patient-solutions.com ↗
Up to $4,000 per calendar year, with each treatment capped at $2,000. The label is a single 1,000 mg infusion, repeated only if iron deficiency anemia recurs, so the $4,000 annual maximum covers two full treatments in the same year. Call 1-800-992-9022 for enrollment questions.
No. Both the Co-pay Program and the Patient Assistance program cover the drug only. The 96365 infusion fee, $67.14 at the Medicare rate, and any office visit are billed separately, whichever program the patient uses.
Data current: programs verified Jul 30, 2026
Monoferric Patient Solutions Copay Assistance Program Program (Pharmacosmos, monoferric.com) · Monoferric Patient Solutions Patient Assistance (Pharmacosmos, monoferric-patient-solutions.com). Every program links directly to its official source or application page.
Last program check: .
Reviewed September 19, 2026 by Erin Rose, CareCost Estimate founder. Methodology →
CareCost